XML 87 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Kenvue Separation - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Aug. 23, 2023
May 08, 2023
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Jul. 02, 2023
Jan. 01, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Common stock, par value per share (in usd per share)     $ 1.00   $ 1.00     $ 1.00
Proceeds from Kenvue initial public offering (Note 12)         $ 4,241 $ 0    
Realized gain (loss) on investment   $ 2,500            
Common stock received in exchange offer $ 31,400              
Accumulated other comprehensive loss     $ 8,780   8,780     $ 12,967
Transition service agreement, term 24 months              
Separation costs incurred     $ 330 $ 249 $ 912 $ 619    
Consumer Health                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Net assets divested $ 11,600              
Accumulated other comprehensive loss 4,300              
Decrease in noncontrolling interest 1,200              
Noncash gain on exchange offer $ 21,000              
Minimum                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Transition manufacturing agreement, term 3 months              
Maximum                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Transition manufacturing agreement, term 5 years              
Kenvue Inc.                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Split-off percentage 80.10%              
Kenvue Inc.                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Common stock, par value per share (in usd per share)   $ 0.01            
Sales price per share (in usd per share)   $ 22.00            
Stock issued in exchange offer (in shares) 1,533,830,450              
Kenvue Inc.                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Stock issued in exchange offer (in shares) 190,955,436              
Kenvue Inc. | Johnson & Johnson                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Percentage ownership after transaction   89.60%            
Common stock, value             $ 1,300  
Percentage ownership after transaction 9.50%              
Equity securities, fair market value $ 4,300              
Kenvue Inc. | Johnson & Johnson | Consumer Health                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Noncash gain on exchange offer $ 2,800              
IPO | Kenvue Inc.                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Shares issued in transaction (in shares)   198,734,444            
Proceeds from Kenvue initial public offering (Note 12)   $ 4,200